Trial intelligence / Profile preview

Ketorolac vs Nepafenac for CME Prevention After Cataract Surgery

NCT02084576Phase 4Completed

Sponsor
Hospital Oftalmológico de Brasília
Start
Aug 2013
Primary completion
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nepafenac in cystoid macular edema (CME), sponsored by Hospital Oftalmológico de Brasília. Started Aug 2013; status: completed.

02

Drugs

nepafenac
03

Conditions

cystoid macular edema (CME)

Beyond the preview

Go deeper on NCT02084576.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02084576.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call